{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:09:14Z","timestamp":1791234554118,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.bbamem.2004.01.010","type":"journal-article","created":{"date-parts":[[2004,2,13]],"date-time":"2004-02-13T10:06:52Z","timestamp":1076666812000},"page":"212-218","source":"Crossref","is-referenced-by-count":81,"title":["Hexadecylphosphocholine interaction with lipid monolayers"],"prefix":"10.1016","volume":"1661","author":[{"given":"Micha\u00eblle","family":"Rakotomanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe M.","family":"Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Saint-Pierre-Chazalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamem.2004.01.010_BIB1","series-title":"Eleventh Programme Report of the World bank\/WHO Special Research Programme and Training in Tropical Disease","article-title":"Tropical disease research progress 1991\u20131992","author":"World Health Organization","year":"1993"},{"key":"10.1016\/j.bbamem.2004.01.010_BIB2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0738-081X(96)00057-0","article-title":"Leishmaniasis: public health aspects and control","volume":"14","author":"Desjeux","year":"1996","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","article-title":"The increase in risk factors for leishmaniasis worldwide","volume":"95","author":"Desjeux","year":"2001","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.bbamem.2004.01.010_BIB5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failure in Indian kala-azar is do to emergence of antimony-resistant strains of Leishmania donovani","volume":"180","author":"Lira","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of Pentavalent Antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4269\/ajtmh.1995.52.149","article-title":"Neurologic changes in visceral leishmaniasis","volume":"52","author":"Hashim","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.38.5.1079","article-title":"Effect of ketoconazole on lethal action of Amphotericin B on Leishmania mexicana promastigotes","volume":"38","author":"Ramos","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.42.2.352","article-title":"Mechanism of Amphotericin B resistance in Leishmania donovani promastigotes","volume":"42","author":"Mbongo","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/infdis\/165.2.337","article-title":"Inhibiting cholesterol synthesis reduces the binding and toxicity of Amphotericin B against rabbit renal tubular cells in primary culture","volume":"165","author":"Joly","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/jac\/33.2.203","article-title":"Administering amphotericin B\u2014a practical approach","volume":"33","author":"Khoo","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/515085","article-title":"US Food and Drug administration approval of Ambisome (liposomal amphotericin B) for treatment of visceral leishmaniasis","volume":"28","author":"Meyerhoff","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/00034989858998","article-title":"Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B\u2013lipid complex","volume":"92","author":"Sundar","year":"1998","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0035-9203(00)90277-3","article-title":"Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis","volume":"94","author":"Sundar","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB15","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/317443","article-title":"Editorial response: choosing amphotericin B formulations\u2014between a rock and a hard place","volume":"31","author":"Bennett","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1201-9712(00)90078-X","article-title":"Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches","volume":"4","author":"Murray","year":"2000","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000420840","article-title":"Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients","volume":"34","author":"Unger","year":"1992","journal-title":"Prog. Exp. Tumor Res."},{"issue":"2","key":"10.1016\/j.bbamem.2004.01.010_BIB18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF00685608","article-title":"Alkylphosphocholines: a new class of membrane-active anticancer agents","volume":"32","author":"Hilgard","year":"1993","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB19","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral Miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB20","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1128\/AAC.44.11.3235-3236.2000","article-title":"Suppression of post treatment recurrence of experimental visceral leishmaniasis in T-cell-deficient mice by oral miltefosine","volume":"44","author":"Murray","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB21","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1086\/322689","article-title":"Treatment of American cutaneous leishmaniasis with Miltefosine, an oral agent","volume":"33","author":"Soto","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0005-2760(94)90133-3","article-title":"Uptake, subcellular distribution and metabolism of the phospholipid analogue hexadecylphosphocholine in MDCK cells","volume":"1211","author":"Geilen","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2004.01.010_BIB23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0166-6851(84)90004-5","article-title":"Sterols of Leishmania species. Implications for biosynthesis","volume":"10","author":"Goad","year":"1984","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0005-2736(00)00161-9","article-title":"Oligonucleotide delivery by cationic derivative of the polyene antibiotic amphotericin B: II. Study of the interactions of the oligonucleotide\/cationic vector complexes with lipid monolayers and unilamellar vesicles","volume":"1464","author":"Blanc","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2004.01.010_BIB25","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1021\/la9601263","article-title":"Incorporation of exogenous molecules inside mono- and bilayers of phospholipids: influence of the mode of preparation revealed by SERRS and surface studies","volume":"12","author":"Heywang","year":"1996","journal-title":"Langmuir"},{"key":"10.1016\/j.bbamem.2004.01.010_BIB26","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0005-2736(88)90519-6","article-title":"Amphotericin B\u2013sterol complex formation and competition with egg phosphatidylcholine: a monolayer study","volume":"944","author":"Saint-Pierre-Chazalet","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2004.01.010_BIB27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0005-2736(69)90160-6","article-title":"Mixed monolayers of phospholipids and cholesterol","volume":"183","author":"Chapman","year":"1969","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0005-2736(72)90117-4","article-title":"Monolayer interaction of individual lecithins with natural sterols","volume":"266","author":"Ghosh","year":"1972","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamem.2004.01.010_BIB29","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/0040-6090(94)90590-8","article-title":"Cholesterol\u2013phospholipid interaction: a monolayer study","volume":"244","author":"Mozaffary","year":"1994","journal-title":"Thin Solid Films"},{"key":"10.1016\/j.bbamem.2004.01.010_BIB30","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1021\/bi00571a005","article-title":"Structure and thermodynamic properties of the complexes between phospholipase A2 and lipid micelles","volume":"18","author":"Soares de Araujo","year":"1979","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamem.2004.01.010_BIB31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00278-4","article-title":"Ether-lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether-lipid analogues in Leishmania","volume":"111","author":"Lux","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbamem.2004.01.010_BIB32","series-title":"The Physical Chemistry of Lipids: from Alkanes to Phospholipids","first-page":"395","author":"Small","year":"1986"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273604000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005273604000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T18:37:34Z","timestamp":1623695854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005273604000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0005273604000434"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamem.2004.01.010","relation":{},"ISSN":["0005-2736"],"issn-type":[{"value":"0005-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}